Trans-anal Eco-doppler Evaluation of Haemorrhoidal Vascularization After Percutaneous Hemorrhoidal Artery Embolization. A Pilot Study.
1 other identifier
observational
10
1 country
1
Brief Summary
To evaluate the usefulness of endoanal ultrasound in the evaluation of emorrhoidal artery embolization outcomes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2022
CompletedFirst Posted
Study publicly available on registry
November 28, 2022
CompletedStudy Start
First participant enrolled
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2023
CompletedFebruary 27, 2023
February 1, 2023
1 month
November 16, 2022
February 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
the reduction in the blood supply
The primary aim was to assess the reduction in the blood supply by comparing the hemorrhoidal arterial systolic peak (overall and sectorial) before and after Emborrhoid.
one month
Secondary Outcomes (1)
correlate the systolic peak reduction at the doppler analysis with the patients' symptoms improvement.
one month
Study Arms (1)
patients candidate to the haemorrhoidal artery embolization
Consecutive patients assessed at the Division of General Surgery 1, Treviso Regional Hospital, from October to December 2021 and candidate to the haemorrhoidal artery embolization were included in the study. Indications to the procedure were symptomatic hemorrhoidal disease (French bleeding score \[FBS\] \> 4), Goligher's classification score II or III, age \>18 years, failure of non-operative management (change life style, dietary modification, supplemental fibers for constipation, over-the-counter treatments). Signed informed and research consents were obtained. Exclusion criteria were age \< 18 years, Goligher prolapse score IV, pregnancy, previous haemorrhoidal surgery, inflammatory bowel disease. Use of anticoagulant or antiaggregant was not considered an exclusion criteria \[stecca\].
Interventions
The primary aim was to assess the reduction in the blood supply by comparing the hemorrhoidal arterial systolic peak (overall and sectorial) before and after Emborrhoid.
Eligibility Criteria
Consecutive patients assessed at the Division of General Surgery 1, Treviso Regional Hospital, from October to December 2021 and candidate to the haemorrhoidal artery embolization were included in the study.
You may qualify if:
- symptomatic hemorrhoidal disease (French bleeding score \[FBS\] \> 4), Goligher's classification score II or III, age \>18 years, failure of non-operative management (change life style, dietary modification, supplemental fibers for constipation, over-the-counter treatments).
You may not qualify if:
- age \< 18 years, Goligher prolapse score IV, pregnancy, previous haemorrhoidal surgery, inflammatory bowel disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale Ca Foncello
Treviso, 31100, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Surgeon
Study Record Dates
First Submitted
November 16, 2022
First Posted
November 28, 2022
Study Start
January 19, 2023
Primary Completion
February 19, 2023
Study Completion
March 20, 2023
Last Updated
February 27, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
A prospective observational pilot study was conducted. The primary aim was to assess the reduction in the blood supply by comparing the hemorrhoidal arterial systolic peak (overall and sectorial) before and after Emborrhoid. The secondary aim was to evaluate the efficacy of this treatment by the Hemorrhoidal Bleeding Score and to correlate the systolic peak reduction at the doppler analysis with the patients' symptoms improvement.